ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2016
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed.
- Histopathologic findings of tularemia lymphadenitis.Journal of hematopathology · 2026Article
- An 8-step procedure-specific risk framework enables reproducible biosafety level assignment beyond agent-based classification.Frontiers in bioengineering and biotechnology · 2026Article
- Sources and culture methods for the isolation and cultivation ofFrontiers in microbiology · 2026Review
- A review of post-exposure strategies for high-consequence viral pathogens in the laboratory.Clinical microbiology reviews · 2025Review
- Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2024.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025Article
- Assessing global pandemic risks from emerging infectious diseases and high containment laboratory leaks: A country-level spatial network SIR model analysis.Risk analysis : an official publication of the Society for Risk Analysis · 2025Article
- Unmet Expectations: Life Scientists' Views on Biorisk and Responsibility.Applied biosafety : journal of the American Biological Safety Association · 2025Article
- [Laboratory Biosafety Guideline (2025) Revision].Jugan geon-gang gwa jilbyeong · 2025Article
- Enhancing safety with an AI-empowered assessment and monitoring system for BSL-3 facilities.Heliyon · 2025Article
- Prosthetic joint infection as an unusual presentation ofIDCases · 2025Article
- The study of biosafety risk identification and analysis for facilities in biosafety level 3 laboratories.Frontiers in cellular and infection microbiology · 2025Article
- Serological and molecular prevalences and phylogenetic analysis ofVeterinary world · 2024Article
- Biosafety, biosecurity, and bioethics.Monash bioethics review · 2024Review
- Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016-2022.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024Article
- Infections in laboratories and the potential of nudge interventions.Health science reports · 2024Article
- Non-vaccinal prophylaxis of tularemia.Frontiers in microbiology · 2024Review
- Association of work ability with job burnout and sleep quality among biosafety laboratory personnel in Xinjiang, China: a cross-sectional study.Frontiers in public health · 2024Article
- The state of biosafety across China's CDC microbiology laboratories: insights from a nationwide survey (2021-2023).Frontiers in public health · 2024Article
- Preparation for the next pandemic: challenges in strengthening surveillance.Emerging microbes & infections · 2023Article
- The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Applied biosafety : journal of the American Biological Safety Association · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laboratory-acquired infections due to a variety of bacteria, viruses, parasites, and fungi have been described over the last century, and laboratory workers are at risk of exposure to these infectious agents. However, reporting laboratory-associated infections has been largely voluntary, and there is no way to determine the real number of people involved or to know the precise risks for workers. In this study, an international survey based on volunteering was conducted in biosafety level 3 and 4 laboratories to determine the number of laboratory-acquired infections and the possible underlying causes of these contaminations. The analysis of the survey reveals that laboratory-acquired infections have been infrequent and even rare in recent years, and human errors represent a very high percentage of the cases. Today, most risks from biological hazards can be reduced through the use of appropriate procedures and techniques, containment devices and facilities, and the training of personnel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.